Benjamin F. Edwards & Company’s Global Cord Blood Corporation CO Stock Holding History

Benjamin F. Edwards & Company’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-59,053	Closed	–	–	1878
2023 Q1	$0	Hold	59,053	–	–	﹤0.01%	1945
2022 Q4	$0	Hold	59,053	–	–	﹤0.01%	1943
2022 Q3	$176K	Buy	+59,053	New	+$145K	0.01%	712

Other funds holding CO

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return

Operose Advisors Milwaukee, Wisconsin $431M AUM 20.45% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Benjamin F. Edwards & Company's CO Position: Q2 2023 in Review

Benjamin F. Edwards & Company sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 59,053 shares.

Benjamin F. Edwards & Company first reported a position in CO in Q3 2022 and held it in 3 quarters. The position peaked at $176K in Q3 2022. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

Benjamin F. Edwards & Company reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
Benjamin F. Edwards & Company sold 59,053 Global Cord Blood Corporation shares in Q2 2023.
Benjamin F. Edwards & Company first reported a position in Global Cord Blood Corporation in Q3 2022 and held it in 3 quarters.
Benjamin F. Edwards & Company's Global Cord Blood Corporation position peaked at $176K in Q3 2022.
6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2023, filed 15 Aug 2023.